V T DeVita

1.8k total citations
23 papers, 1.3k citations indexed

About

V T DeVita is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, V T DeVita has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 10 papers in Genetics and 7 papers in Oncology. Recurrent topics in V T DeVita's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Multiple and Secondary Primary Cancers (4 papers). V T DeVita is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Multiple and Secondary Primary Cancers (4 papers). V T DeVita collaborates with scholars based in United States, Malaysia and India. V T DeVita's co-authors include Robert C. Young, Elaine S. Jaffe, Daniel C. Ihde, S M Hubbard, D L Longo, Eli Glatstein, P L Duffey, Daniele Longo, RC Young and Margaret N. Wesley and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

V T DeVita

22 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
V T DeVita United States	12	679	455	279	206	180	23	1.3k
T. H. Ittel Germany	17	377 0.6×	421 0.9×	190 0.7×	132 0.6×	60 0.3×	52	1.2k
Sverre Harvei Norway	15	431 0.6×	399 0.9×	176 0.6×	421 2.0×	81 0.5×	26	1.5k
Kenneth B. Olson United States	16	165 0.2×	461 1.0×	253 0.9×	514 2.5×	131 0.7×	42	1.2k
Niels T. Pedersen Denmark	17	924 1.4×	586 1.3×	186 0.7×	188 0.9×	257 1.4×	35	1.5k
B. E. Roberts United Kingdom	22	340 0.5×	281 0.6×	337 1.2×	94 0.5×	18 0.1×	68	1.5k
Ajay Gogia India	19	272 0.4×	441 1.0×	197 0.7×	156 0.8×	67 0.4×	192	1.1k
Alain Monnereau France	14	278 0.4×	306 0.7×	214 0.8×	116 0.6×	41 0.2×	42	868
Kari G. Chaffee United States	21	601 0.9×	726 1.6×	659 2.4×	144 0.7×	48 0.3×	43	1.8k
Richard K. Desser United States	19	218 0.3×	428 0.9×	70 0.3×	354 1.7×	35 0.2×	30	995
W. Heller Germany	15	148 0.2×	389 0.9×	124 0.4×	169 0.8×	29 0.2×	81	1.5k

Countries citing papers authored by V T DeVita

Since Specialization

Citations

This map shows the geographic impact of V T DeVita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V T DeVita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V T DeVita more than expected).

Fields of papers citing papers by V T DeVita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V T DeVita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V T DeVita. The network helps show where V T DeVita may publish in the future.

Co-authorship network of co-authors of V T DeVita

This figure shows the co-authorship network connecting the top 25 collaborators of V T DeVita. A scholar is included among the top collaborators of V T DeVita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V T DeVita. V T DeVita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muggia, Franco M., Vincent H. Bono, & V T DeVita. (2015). New Anticancer Drugs. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 23. 42–49.

Longo, D L, P L Duffey, V T DeVita, et al.. (1991). The calculation of actual or received dose intensity: a comparison of published methods.. Journal of Clinical Oncology. 9(11). 2042–2051. 153 indexed citations

Surbone, Antonella, D L Longo, V T DeVita, et al.. (1988). Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management.. Journal of Clinical Oncology. 6(12). 1832–1837. 134 indexed citations

Kant, Jet, et al.. (1986). The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease.. Journal of Clinical Oncology. 4(3). 284–294. 76 indexed citations

DeVita, V T, et al.. (1983). IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Food and Chemical Toxicology. 21(4). 509–510. 347 indexed citations

Lees, David Eric, et al.. (1982). Erythrocyte osmotic fragility in patients receiving hyperthermia with and without chemotherapy.. PubMed. 65(11-12). 1103–4. 1 indexed citations

Fisher, R I, et al.. (1981). Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma. Blood. 58(1). 45–51. 134 indexed citations

Fisher, R I, et al.. (1981). Factors predicting long-term survival in diffuse mixed, histiocytic, or undifferentiated lymphoma. Blood. 58(1). 45–51. 4 indexed citations

Anderson, Thomas, Richard A. Bender, Stephen H. Rosenoff, et al.. (1977). Peritoneoscopy: a technique to evaluate therapeutic efficacy in non-Hodgkin's lymphoma patients.. PubMed. 61(6). 1017–22. 8 indexed citations

10.

Young, Robert C., R E Johnson, George P. Canellos, et al.. (1977). Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination.. PubMed. 61(6). 1153–9. 38 indexed citations

11.

Gp, Canellos, et al.. (1976). Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy. Blood. 47(6). 1003–1009. 2 indexed citations

12.

Ihde, DC, V T DeVita, Canellos Gp, & RC Young. (1976). Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. Blood. 47(2). 211–222. 1 indexed citations

13.

Gp, Canellos, V T DeVita, J. Whang‐Peng, et al.. (1976). Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapy. Blood. 47(6). 1003–1009. 56 indexed citations

14.

DeVita, V T, et al.. (1975). In vitro granulocyte production in patients with Hodgkin's disease and lymphocytic, histiocytic, and mixed lymphomas. Blood. 45(6). 833–842. 2 indexed citations

15.

DeVita, V T, et al.. (1975). In vitro granulocyte production in patients with Hodgkin's disease and lymphocytic, histiocytic, and mixed lymphomas. Blood. 45(6). 833–842. 12 indexed citations

16.

Schein, Philip S., et al.. (1975). Results of combination chemotherapy of non-Hodgkin's lymphoma.. PubMed. 2. 465–73. 16 indexed citations

17.

Muggia, Franco M. & V T DeVita. (1972). In vivo tumor cell kinetic studies: use of local thymidine injection followed by fine-needle aspiration.. PubMed. 80(2). 297–301. 11 indexed citations

18.

Canellos, G P, et al.. (1972). Late Recurrence of Testicular Tumor. New England Journal of Medicine. 287(8). 413–413. 8 indexed citations

19.

Corder, Michael P., Robert C. Young, & V T DeVita. (1971). Delayed Hypersensitivity in Patients with Cancer. New England Journal of Medicine. 285(9). 522–524. 8 indexed citations

20.

Bennett, J M, H. R. Gralnick, & V T DeVita. (1968). Bone-Marrow Biopsy in Hodgkin's Disease. New England Journal of Medicine. 278(21). 1179–1179. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact